ease is an inherited disorder of skeletal muscle function, characterized by exercise-induced impairment of Sarcolipin (SLN) is a low-molecular-weight protein that copurifies with the fast-twitch skeletal muscle muscle relaxation. Mutations in the ATP2A1 gene encoding SERCA1 have been associated with the autoso-sarcoplasmic reticulum Ca 2/ ATPase (SERCA1). Genomic DNA and cDNA encoding human sarcolipin (SLN) mal recessive inheritance of Brody disease in three families, but not with autosomal dominant inheritance were isolated and characterized and the SLN gene was mapped to chromosome 11q22-q23. Human, rabbit, of the disease. A search for mutations in the SLN gene in five Brody families, four of which were not linked and mouse cDNAs encode a protein of 31 amino acids. Homology of SLN with phospholamban (PLN) suggests to ATP2A1, did not reveal any alterations in coding, splice junction or promoter sequences. The homozy-that the first 7 hydrophilic amino acids are cytoplasmic, the next 19 hydrophobic amino acids form a gous deletion of C438 in the coding sequence of ATP2A1 in Brody disease family 3, leading to a single transmembrane helix, and the last 5 hydrophilic amino acids are lumenal. The cytoplasmic and trans-frameshift and truncation following Pro 147 in SERCA1, is the fourth ATP2A1 mutation to be associated with membrane sequences are not well conserved among the three species, but the lumenal sequence is highly autosomal recessive Brody disease. ᭧ 1997 Academic Press conserved. Like SERCA1, SLN is highly expressed in rabbit fast-twitch skeletal muscle, but it is expressed to a lower extent in slow-twitch muscle and to an even INTRODUCTION lower extent in cardiac muscle, where SERCA2a and PLN are highly expressed. It is expressed in only trace amounts in pancreas and prostate. SLN and PLN genes Sarcolipin resemble each other in having two small exons, with their entire coding sequences lying in exon 2 and a Sarcolipin (SLN) was first isolated as a low-molecularge intron separating the two segments. Brody dislar-weight proteolipid from rabbit fast-twitch skeletal muscle sarcoplasmic reticulum and from preparations of the Ca 2/ ATPase (SERCA1) purified from that source Sequence data from this article have been deposited with the Gen-Bank/EMBL Data Libraries under Accession Nos. U96091, rabbit (MacLennan et al., 1972) . Attempts were made to dis-cDNA; U96092, U96093, human gDNA; U96094, human cDNA. cover a function for SLN, by reconstitution of the pro-1 To whom correspondence should be addressed. Telephone teolipid with purified preparations of SERCA1 and
SLN was reported to enhance the coupling ratio be-Brody families. In later studies, Benders et al. (1994) were unable to measure a decrease in SERCA1 protein tween Ca 2/ uptake and Ca 2/ -dependent ATP hydrolysis when reconstituted with SERCA1, but, when puri-content in skeletal muscle from seven Brody families, but SERCA1 activity was reduced by 50%. fied SLN was added to the exterior of these reconstituted liposomes, Ca 2/ accumulation was diminished,
We have reported the association of some cases of Brody disease with the autosomal recessive inheritance implying that SLN might act as a Ca 2/ ionophore (Racker and Eytan, 1975) . MacLennan et al. (1980) of mutations in the ATP2A1 gene, encoding SERCA1, in two Brody families (Odermatt et al., 1996) , but fractionated SLN away from SERCA1, reconstituted the highly purified SERCA1 in lipid bilayers, and found ATP2A1 was ruled out as a candidate gene in three other Brody families in an earlier study (Zhang et al., no alteration in Ca 2/ /ATP coupling ratios before and after removal of SLN. Later studies by Maruyama and 1995) , demonstrating that the cause of the disease is heterogeneous. Some of the non-ATP2A1-linked fami-MacLennan (1988) showed that SERCA1 cDNA, expressed alone in heterologous cell culture, yielded mi-lies were characterized by dominant inheritance of the disease. Since SERCA1 content was reported to be nor-crosomal membranes containing fully functional Ca 2/ uptake and Ca 2/ -dependent ATPase activities, sug-mal, but with reduced activity in seven Brody patients studied by Benders et al. (1994) , we deduced that a gesting that SLN plays no essential role in Ca 2/ uptake. The protein was sequenced by Wawrzynow et al. candidate gene for Brody disease might encode a protein that would interact with SERCA1 and, when mu-(1992) and named sarcolipin.
In studies of the yeast H / ATPase, Navarre et al. tated, become a dominant inhibitor of SERCA1 function. Accordingly, the human SLN gene was evaluated (1992) discovered that two low-molecular-weight proteolipids are associated with this P-type ATPase. In as a candidate gene for Brody disease. Unfortunately, we were unable to find any alterations in coding, splice double mutants, lacking both proteolipids, the V max of the H / ATPase was reduced to 50% of that of wild junction, or promoter sequences that would support SLN as a candidate gene for Brody disease in five pa-type strains (Navarre et al., 1994) . The mechanism of interaction of these proteolipids with the H / ATPase tients. has not been determined.
Phospholamban (PLN) is a 52-amino-acid protein lo-
MATERIALS AND METHODS
cated in the sarcoplasmic reticulum of cardiac, slowtwitch, and smooth muscles, where it acts as an inhibi-Preparation of RNA and RT-PCR. Total RNA was isolated from tor of SERCA2 by lowering its apparent affinity for normal human skeletal muscle using guanidium-isothiocyanate-Ca 2/ (Tada and Katz, 1982) . The protein has a hydrophenol-chloroform extraction (Chomczynski and Sacchi, 1987) . A 5philic N-terminal sequence of 30 amino acids, which mg aliquot of total RNA was reverse transcribed in 50 ml of a reaction would alter its solubility by comparison with low-momix (Stratagene cDNA synthesis kit) containing 50 U of MMuLV reverse transcriptase at 37ЊC in the presence of RNase Block Inhibilecular-weight proteolipids, but, in respect to its intertor and 0.5 mg of random primers. Following first-strand cDNA synaction with a P-type cation pump, it resembles other thesis, RNA was hydrolyzed by the addition of 50 ml of 0.3 N sodium proteolipids.
hydroxide and 30 mM EDTA and boiling for 5 min. The pH was then
In this paper, we characterize the sarcolipin (SLN) neutralized with 25 ml of Tris-HCl, pH 8.3. After extraction with phenol and chloroform, the cDNA was precipitated with ethanol and gene and demonstrate structural similarities between washed, and the pellet was dissolved in 30 ml of H 2 O. Aliquots of 1 the SLN and PLN genes, as well as homology between ml of first-strand cDNA were used as the template in subsequent the peptide sequences of their products. SLN gene tran-PCR amplifications. scription is shown to be high in fast-twitch skeletal PCR cloning of partial SLN cDNA based on known peptide semuscle, where SERCA1 expression predominates. By quence. Reverse translation of the amino acid sequence of rabbit contrast, PLN gene transcription was shown earlier to sarcolipin (Wawrzynow et al., 1992) permitted the synthesis of two fully degenerate oligonucleotide primers, SALF7 and SALR7 (Table   be high in cardiac muscle, where SERCA2a expression 1), based on the 5 and 3 ends of the cDNA coding sequence. The predominates (Fujii et al., 1988) .
oligonucleotide primers also contained nine nucleotide BamHI restriction endonuclease sites at their 5 ends to facilitate subsequent cloning of PCR products. PCR amplification with primers SALF7 and
Brody Disease
SALR7 was carried out using either 100 ng of DNA from a fulllength rabbit skeletal muscle cDNA library (MacLennan et al., 1985) Brody disease is an inherited disorder of skeletal constructed in the pcDX vector (Okayama and Berg, 1983) or, altermuscle function, characterized by exercise-induced imnatively, using 1 ml of first-strand cDNA derived from normal human pairment of muscle relaxation. Studies of the sarcoplasskeletal muscle as a template. Taq polymerase and Taq Extender mic reticulum from Brody patients have shown de-(Stratagene) were used for PCR amplification in the buffer supplied. creased Ca 2/ uptake and Ca 2/ -dependent ATP hydroly-Denaturation was for 1 min at 94ЊC, annealing was at 57ЊC for 2 min, and extension for 30 cycles was at 72ЊC for 2 min, followed by sis. (Brody, 1969; Karpati et al., 1986: Danon et al., a final extension at 72ЊC for 10 min. Amplified DNA obtained using 1988; Taylor et al., 1988; Wevers et al., 1992 ; Poels et either rabbit or human template was cloned into the BamHI site al., Benders et al., 1994) . In the studies of Karpati of the Bluescript vector BsKs(/) (Stratagene). The coding sequence et al. (1986) , no immunologically reactive ATPase was between degenerate primers was 45 bp long for both the rabbit and the human SLN genes.
observed in fast-twitch fibers of probands from two Cloning of rabbit SLN cDNA. Knowledge of the 45-bp sequence taining 50 ng of circularized BsiWI DNA was used as a template in of rabbit SLN cDNA lying between primers SALF7 and SALR7 (Table an inverse PCR amplification with primers SALF10 and SALR10 1) permitted the design of additional primers (SALF9, SALR9) for ( Table 1 ). The PCR product of 1.1 kb was cleaved with BamHI, inverse long PCR amplification in which the cDNA and the whole cloned into Bluescript, and the sequence of the 5 end of human pcDX vector sequence were included. PCR amplification was carried SLN cDNA was determined. All eight clones analyzed started at out with Taq polymerase:Pfu polymerase (5:1 ratio), using 100 ng of the A residue at position /6 of the cDNA sequence (Figs. 1B and the full-length rabbit skeletal muscle cDNA library in pcDX as a 2). In addition, cDNA was reamplified with primers HSAF5 and template. An initial hot start at 94ЊC for 2 min preceded 30 cycles HSAR5 from human first-strand cDNA, and the sequence of the of denaturation at 94ЊC for 30 s, annealing at 62ЊC for 1 min, and 0.7-kb product was verified by cycle sequencing. elongation at 72ЊC for 10 min. A single product of about 4.5 kb was Determination of the human SLN gene structure. Two primers at purified on a 1% agarose gel and extracted with a gel extraction kit both ends of the full-length cDNA (HSAF5 and HSAR5) were used from Qiagen. About 10 ng of the product was then blunt ended by to amplify human genomic DNA. A single DNA product of 4.5 kb incubation with 0.7 U/ml mung bean nuclease for 30 min at 37ЊC; with a single intron in the 5 untranslated region of the cDNA was the DNA was extracted with phenol and chloroform, precipitated, obtained. Flanking genomic DNA sequences were obtained by inand self ligated for 12 h at 12ЊC using 5 U of T4 DNA ligase in a verse PCR, in which 4 mg of human genomic DNA was cleaved with volume of 200 ml. Transformation of competent DH5a cells and selec-EcoRI, BglII, or HindIII, extracted with phenol and chloroform, pretion for ampicillin resistance conferred by the coamplified pcDX veccipitated with 50% isopropanol containing 250 mM sodium acetate, tor yielded over 1000 colonies. The sequence of the full-length rabbit washed once with 70% ethanol, and self ligated. The inverse long muscle cDNA was determined using a T7 sequencing kit (Phar-PCR amplification used 50 ng of circularized DNA with a primer macia). To exclude any PCR cloning artifacts, rabbit SLN cDNA was pair corresponding to the 5 (HSAF8, HSAR8) or the 3 (HSAF1, also amplified with two oligonucleotides, RSAF7 and RSAR8 (Table  HSAR1 ) segments of the cDNA, respectively. For the 3 end, single 1), using the pcDX library as a template. The sequence of the 0.7products of 5.7 and 3.5 kb were obtained from the BglII and HindIII kb product was verified by cycle sequencing. circularized genomic DNA fragments, but no product was observed Cloning of human SLN cDNA. The 3 end of the human SLN when EcoRI circularized DNA was used as a template. For the 5 cDNA was cloned by application of the 3 RACE technique (Innis region, 5-, 4-, and 0.9-kb products were obtained for BglII, HindIII, et al., 1990) in which 5 mg of total RNA from human skeletal muscle and EcoRI, respectively ( Fig. 1A) . was reverse transcribed with primer RACE1 (Table 1) 
as described
Primer extension. Total RNA was isolated from normal human above. Subsequent PCR amplification with primers RACE3 and skeletal muscle of two unrelated individuals as described above. The HSAF1 using Taq polymerase:Pfu polymerase (5:1 ratio) yielded oligonucleotides HSAR8 or HPE1 (Table 1) were labeled with polya single product of 550 bp, which was cleaved with BamHI and nucleotide kinase and [g-32 P]ATP to a specific activity of 300 nCi/ng. cloned into the Bluescript vector. Sequence analysis indicated that Thirty micrograms of total RNA in 30 ml of hybridization buffer (40 all eight clones analyzed were identical. The 5 end of human SLN mM Pipes (1,4-piperazine-diethanesulfonic acid), pH 6.4, 1 mM cDNA was cloned by PCR amplification from a lgt11 5 stretch EDTA, 0.4 M NaCl, 80% formamide) was denatured for 5 min at cDNA library, kindly provided to us by Drs. Peter Ray and Perry 90ЊC and annealed overnight at 30ЊC with 3 ng of the labeled oligonu-Howard, Hospital for Sick Children, Toronto. Phage DNA was precleotide. The nucleic acids were ethanol precipitated, washed, and pared according to the l phage library protocol from Stratagene, reverse transcribed as described above. The final pellet was dissolved in which 1 mg of lgt11 DNA is cleaved by BsiWI (which cuts at both sides of the cDNA inserts) and self ligated. An aliquot con-in 4 ml of water, and 6 ml of formamide loading buffer was added.
Three microliters of the product, corresponding to 10 mg of reverse transcribed total RNA, was analyzed by electrophoresis on a 7.2% denaturing polyacrylamide sequencing gel. Northern blots. Northern blots, containing 8 mg of total RNA from rabbit fast-twitch (psoas) and slow-twitch (soleus) skeletal muscle, were prepared and treated as described by Ausubel et al. (1994) . Multiple tissue Northern (MTN) blots, loaded with 2 mg per lane of poly(A) / RNA derived from a number of human tissues, were purchased from Clontech. A gel-purified, 0.5-kb PCR fragment amplified with primers HSAF1 and HSAR5 from human cDNA and a 2-kb human b-actin cDNA probe (Clontech) were labeled with [ 32 P]dCTP using random primers and T7 polymerase. Hybridization was carried FIG. 1. (A) Structure and restriction map of human SLN. The out for 1 h at 68ЊC using ExpressHyb solution (Clontech) containing upper line shows the restriction endonuclease map of the gene dethe labeled probe at a final concentration of 5 ng/ml (1 1 10 6 CPM/ rived from clones obtained by PCR amplification. Restriction endonuml). The MTN blots were subjected to autoradiography for 2, 16, and clease sites are: E, EcoRI; B, BglII; H, HindIII. The locations of the 72 h, at 070ЊC using Kodak b-max film and two intensifying screens.
two exons within the gene (solid boxes) and the location of the coding The blots were stripped and probed for b-actin mRNA according to sequence within exon 2 (white box) are indicated on the lower line. the protocol of the manufacturer. Autoradiography was for 4 h.
The positions of the TATA and CCAAT sequences, the ATG initiation Southern blots. Multiple species Southern (Zoo) blots, loaded codon, and polyadenylation signal sequences are marked. (B) Nucleowith 4 mg of genomic DNA cleaved with the restriction endonuclease tide and deduced amino acid sequences of human SLN. Upstream EcoRI, were purchased from Clontech and hybridized according to nucleotides, in lowercase, are numbered negatively, on the left, to the instructions of the manufacturer. Either the 0.5-kb HSAF1the transcription initiation site. Exon sequences are in uppercase and HSAR5 probe, specific for exon 2 (described above), or the 350-bp numbered positively thereafter. The sequence of the single intron is probe obtained with primers HSAF12 and HSAR8, specific for the presented in lowercase and is not numbered. Numbers relative to 5 region of the SLN gene, was used. The blot was washed at low the cDNA at the ends of both exons are in parentheses below the stringency (21 SSC, 0.05% SDS; 60ЊC).
sequence. Putative DNA binding elements for eukaryotic transcrip-Chromosomal mapping of the SLN gene. To determine the chrotional factors are underlined and identified below the sequence. The mosomal localization of the SLN gene, a 4.5-kb, PCR-amplified geno-GenBank accession number for these sequences are U96092mic DNA fragment (HSAF5 and HSAR5) was used for fluorescence U96094. in situ hybridization (FISH) experiments. FISH was performed following the procedure of Lichter et al. (1990) , by counterstaining the chromosomes with propidium iodide and DAPI. The biotinylated fication and cycle sequencing were performed as described by Oderprobe was detected with avidin-FITC. Images of metaphase prepamatt et al. (1996) . rations were captured by a thermoelectrically cooled, charge-coupled Case histories. Brody patients F3P3, F4P3, and F5P3 were decamera (Photometrics, Tucson, AZ). Separate images of DAPIscribed as patients 1-3 in Zhang et al. (1995) . Patient F3P3 was also banded chromosomes (Heng and Tsui, 1993) and of FITC-targeted described as patient 1 in Karpati et al. (1986) . Patient F6P3 had a chromosomes were obtained. Hybridization signals, pseudocolored long history of exercise-and cold-induced muscle stiffness, pain, and yellow for FITC and pseudocolored blue for DAPI-stained chromocramps. Treatment with Verapamil produced impressive improvesomes, were overlaid electronically and merged using Adobe Phoment in his symptoms. His mother and sister were said to suffer toshop 3.0 software. The band assignment was determined by meafrom similar symptoms, suggesting dominant inheritance of the dissuring the fractional chromosome length and by analyzing the bandease. No myotonia was observed either clinically or on electrophysioing pattern generated by the DAPI counterstained image. logical testing. Creatine kinase was mildly elevated. Ischemic exer-The chromosomal localization of the SLN gene was confirmed by cise testing showed normal elevation of serum lactate and ammonia. screening the NIGMS somatic cell hybrid panel 2 (Dubois and A muscle biopsy showed nonspecific, mixed myopathic and neuro-Naylor, 1993) and the GeneBridge 4 radiation hybrid (RH) panel pathic features. Patient F7P3 was described as patient 6 in Benders (Walter et al., 1994) , purchased from Research Genetics. Radiation et al. (1994) . hybrid mapping experiments were carried out in duplicate and the data were analyzed at a lod score of ú3.0 using the RH server from the Whitehead Institute/MIT Center for Genomic Research. The
RESULTS
primers used for this specific analysis were HSAF9 and HSAR11 (Table 1) , which amplified a 900-bp human-specific band using the
Characterization of the Human SLN Gene
following conditions: denaturation at 94ЊC for 30 s; annealing at 62ЊC for 2 min; extension at 72ЊC for 2 min, for 35 cycles. The complete set Figure 1A shows the structure and restriction map of RH data is available through the NCBI radiation hybrid mapping service at http://www.ncbi.nlm.gov/SCIENCE96/. of human SLN, and Fig. 1B provides a partial DNA Analysis of mutations in ATP2A1 of patients from Brody families sequence of the human SLN gene. The partial sequence BD3 and BD6. Genomic DNA was amplified, and the 23 ATP2A1 includes: 967 bp of the 5 region containing the probaexons, plus 1500 bp upstream of the transcription initiation site ble promoter of the SLN gene, nuceotides 0967 to 01;
containing the putative promoter region, were sequenced, as deexon 1 nucleotides /1 to /99, which form part of the scribed by Odermatt et al. (1996) . At least 30 bp of flanking sequence 5 untranslated region of the cDNA; about 300 bp of was determined for each exon. sequence at both the 5 and the 3 ends of the single Analysis of SLN sequence in patients of Brody families BD3 (F3) to BD7 (F7). Muscle biopsies were available from Brody patients 3.9-kb intron; exon 2 nucleotides /100 to /719, which F4P3 and F5P3 (Table 2) . First-strand cDNA, prepared as described form the remainder of the 5 untranslated region, the above, was amplified with primers HSAF5 and HSAR5, and the secoding sequence for SLN, and the 3 untranslated requence of the 0.7-kb product was determined by cycle sequencing. gion of the SLN gene; and 556 bp of downstream se-Genomic DNA was isolated from blood from patients F3P3, F6P3, quence. Primer extension analysis using total RNA isoand F7P3, using the Qiaamp blood kit (Qiagen). A 5-kb DNA fragment was amplified with primers HSAF12 and HSAR11. PCR ampli-lated from skeletal muscle of an individual with no tide /719 in Fig. 1B . The total length of the gene is about 5.6 kb.
A search for potential DNA binding elements for known eukaryotic transcriptional factors revealed a cluster of three possible TATA box sequences between 0745 bp and 0783 bp ( Fig. 1B) . Two additional TATA boxes were found between 0945 and 0949 bp and between 0633 and 0636 bp. A CCAAT box was found 45 bp downstream of the TATA box cluster between 0700 and 0704 bp. The CCAAT box of the SLN gene, CTC-CCAATCT, differed from the consensus sequence GGY-CCAATCT (Lewin, 1994) in having pyrimidines rather than purines upstream of the YCCAATCT sequence. Several E box sequences (CANNTG), recognized by the MyoD family of basic helix-loop-helix transcriptional activators (Piette et al., 1990; Weintraub et al., 1990) , were identified in the 5 region of the SLN gene. One pair of E boxes, separated by 11 bp and lying between 0587 and 0609 bp, and a second pair of E boxes, separated by 10 bp and lying between 0198 and 0219 bp, were located downstream of the CCAAT box. In addition, a potential binding site for the myocyte enhancer factor MEF-2 (CTA(A/T) 4 TAG) was identified upstream of the TATA box cluster between 0805 and 0814 bp. The sequence CTTGGTTACAA, with similarity to the MEF-3 enhancer element (TCAGGTTT(T/A)CA) described by Hidaka et al. (1993) , was found just upstream of the MEF-2 motif between 0828 and 0838 bp. An additional MEF-3-like motif (TCAGTTTTGAA) was found between 0497 and 0505 bp. Unlike the MEF-3 consensus sequence, the motifs found in the SLN gene had palindromic ends. We identified a possible site for the transcriptional activator protein AP- Figs. 1B and 2) . The polyadenylasequence is given on the right. The transcription initiation site is indicated by an asterisk. tion site in the major transcript was located at nucleo- 1 (Lee et al., 1987) between 0341 and 0348 bp. The The human sequences were obtained by similar methtranslation initiation signal sequence (Kozak, 1987) at ods, as outlined under Materials and Methods. Sethe end of the promoter sequence (GCTGTGAAAquences from mouse cardiac and skeletal muscle SLN ATGG) is reasonably conserved compared to the conwere obtained from a computer search of the GenBank sensus sequence (GCCGCCA/GCCATGG).
EST database, which also identified human SLN EST Sequencing of the 3 end of the human SLN gene sequences (Washington University School of Medicinerevealed the major polyadenylation signal, AATAAA, Merck EST project) covering most of the full-length between nucleotides 701 and 706, with polyadenylation cDNA, but lacking the 5 and 3 tails. occurring after residue 719. A potential polyadenyla-Comparison of human, rabbit, and mouse SLN tion signal sequence, AATAAA, was also found 252 bp cDNAs revealed 84% nucleotide sequence identity bedownstream of the major polyadenylation signal setween human and rabbit, 44% nucleotide sequence quence. To test whether this downstream polyadenylaidentity between human and mouse, and 41% nucleotional signal was used, PCR analysis was carried out tide sequence identity between mouse and rabbit SLN with a forward primer (HSAF3) in exon 1 and a reverse cDNAs. The higher level of nucleotide sequence idenprimer (HSAR11) at the downstream poly(A) / site. Hutity between the human and rabbit SLN cDNAs is reman skeletal muscle first-strand cDNA primed with flected in their identical length and in their use of the oligo(dT) was used as a template. A product of 660 bp same polyadenylation signal sequence for the major was amplified (not shown), indicating that the longer transcript, 14 bp upstream of the poly(A) / tail. This transcript was, indeed, synthesized. Contamination by polyadenylation site is lacking in the mouse SLN ESTs, genomic DNA was excluded on the basis of the absence which contain a consensus polyadenylation signal seof intronic sequence in the PCR product. We estimate quence 150 bp further downstream, with polyadenylathat the level of the longer transcript was less than 5% tion occurring an additional 100 bp downstream. The of that of the major 719-bp transcript. There was no length of the mouse SLN cDNA is at least 950 bp. An indication of the use of a potential polyadenylation sig-AUUUA motif that could act as an RNA degradation nal sequence, AATTAA, 158 bp upstream of the major signal (Shaw and Kamen, 1986 ) is present in the major signal sequence.
transcript of human and rabbit mRNA, about 250 bp downstream of the stop codon, but is lacking in the Isolation and Analysis of cDNA Clones Encoding mouse transcript. Another potential polyadenylation Rabbit and Human SLN signal sequence, present in all three species, is located 50 bp downstream of the potential RNA degradation Nucleotide sequence. Figure 3 illustrates the nuclesignal. The first 11 nucleotides, which include the otide sequences encoding human, rabbit, and mouse translation initiation signal sequence (Kozak, 1987) , SLN and their deduced amino acid sequences. The rabare not well conserved among the three species. bit sequences were confirmed in eight clones obtained Amino acid sequence. The SLN gene encodes a profrom a cDNA library by circularization, following inverse long PCR amplification from primers in exon 2. tein of 31 amino acids that can be divided into three SLN transcript was found in rabbit fast-twitch skeletal muscle (psoas) than in slow-twitch skeletal muscle (soleus) (Fig. 5C ). the SLN gene (Fig. 6) . A single band was detected in shown by two vertical dots. The asterisk indicates the first and last genomic DNA from each of human (0.9 kb), monkey amino acid of the predicted transmembrane helix of SLN.
Multiple-Species Genomic DNA Analysis
(0.95 kb), dog (1.5 kb), cow (1.05 kb), and rabbit (4.4 kb). The size of 0.9 kb of the EcoRI-digested human domains: a hydrophilic N-terminal domain of 7 amino genomic DNA fragment confirmed the finding of a 0.9acids; a hydrophobic, transmembrane helical domain kb DNA product obtained by inverse PCR amplification of 19 amino acids; and a hydrophilic C-terminal domain with primers specific for the 5 region of the SLN gene. consisting of 5 amino acids. Neither the hydrophilic N-Genomic DNA from chicken yielded two bands of 1.6 terminal sequences nor the hydrophobic transmemand 2.6 kb. The hybridization signal of the human brane sequences are well conserved among the three probe with mouse and rat genomic DNA was very weak, species studied, and changes in net charge occur in reflecting the fact that there is much lower similarity the N-terminal sequences. The hydrophilic C-terminal between human and mouse SLN cDNAs than between sequences are, however, perfectly conserved. The human and rabbit SLN cDNAs. No hybridization to amino acid sequence of the rabbit protein, deduced digested yeast genomic DNA was observed. A similar from the cDNA, is identical to the peptide sequence pattern was obtained using a labeled probe specific for determined by Wawrzynow et al. (1992) .
the 3 region of the SLN gene (not shown). The SLN sequence from residue 4 to residue 26 (4 N-terminal hydrophilic residues and 19 hydrophobic Chromosomal Localization transmembrane residues) shares a striking similarity
To determine the location of the SLN gene, we perwith residues 28 to 49 of PLN (Fig. 4) . This similarity formed FISH using a 4.5-kb, PCR-amplified DNA probe becomes more evident if alternate residues at different covering both exons and the single intron. Positive sigpoints in the sequences of the three species are considnals were observed on both chromosome 11 chromatids ered. Asn 4 in human SLN corresponds to Asn 27 in PLN in the region of 11q22-q23. No hybridization to any in rabbit, pig, and dog. Gln 6 in mouse SLN corresponds other chromosome was observed. The assignment of to Gln 29 in human PLN. At human SLN positions 10, the SLN gene to human chromosome 11 was confirmed 20, and 22 Leu, Ile, and Met differ from the correspondusing monochromosomal rodent-human somatic cell ing residue in human PLN, but in other species, correhybrids. To refine the position of the gene on the genetic spondence of one or more of these residues is observed. and physical map of 11q, we screened the GeneBridge On the basis of these sequence similarities, we propose 4 RH panel. The results indicate that SLN is flanked that SLN and PLN are homologous proteins. Since the by the two genetic markers CHLC.GATAGC11 and orientation of PLN in the membrane is well estab-CHLC.GATA71E06. SLN was 7.04 cR from the former lished, we propose that the N-terminal domain of SLN marker. Although this entire region appears to be covis cytosolic and that the C-terminal domain faces the ered by a set of overlapping YACs (Hudson et al., 1995) , lumen of the sarcoplasmic reticulum.
our analysis failed to detect a positive clone for the SLN gene from this collection. Nevertheless, the FISH Characterization of SLN Expression and RH data are consistent, indicating that the gene The distribution of SLN mRNA in various human maps to human chromosome 11q22-q23. tissues was determined by Northern blot analysis using a PCR-amplified probe from the 3 untranslated Sequencing of SLN from Patients of Brody Families region of the cDNA that hybridized to a single tran-BD3 to BD7 script of 0.7 kb (Fig. 5 ). This SLN transcript was highly expressed in skeletal muscle, but was at least 50-fold No mutations were found in the sequence of the SLN cDNA amplified from patients F4P3 (recessive inheri-less abundant in heart muscle, as determined by densitometry of the exposed film. Only trace amounts were tance, Table 2 ) or F5P3 (dominant inheritance), nor were any mutations found in the sequence of the SLN gene detected in prostate and pancreas. In all other tissues analyzed (brain, placenta, lung, liver, kidney, uterus, amplified from genomic DNA from patients from families BD3 (recessive), BD6 (dominant), or BD7 (dominant) (Ta-colon, small intestine, bladder, and stomach), no SLN transcript was detected. A 9-fold higher level of the ble 2). Genomic sequences included each of the two exons The same blots were probed with a human b-actin cDNA and exposed for 4 h. The second hybridization signal at 1.6-1.8 kb observed in both heart and skeletal muscle is due to probe hybridization to either the a or the g form of actin (Giovanna et al., 1991; Lamballe et al., 1991) . (C) Analysis of SLN expression in rabbit fast-twitch and slow-twitch skeletal muscle. The Northern blot was probed with the 0.7kb RSAF7-RSAR8 PCR product, specific for rabbit SLN mRNA. Autoradiography was for 6 h. and at least 100 bp of intron sequence flanking each exon Sequencing of ATP2A1 from Genomic DNA of and 850 bp of the proposed promoter region. The substitu-Patients F3P3 and F6P3 tion of G for C11 in the 5 untranslated region of exon 2 was detected in patient F3P3. The insertion of a T in Sequence analysis of ATP2A1 from genomic DNA of both alleles at position 0118 was observed in patient patient F6P3 (dominant) did not reveal any mutations F6P3. This mutation did not affect the structure of SLN in the putative promoter region, in the two exons, or and was not considered significant.
in 10-100 bp of intronic sequence flanking each exon. The substitution of T for C678, a polymorphism that does not change the amino acid sequence (Zhang et al., 1995) , was detected in patient F6P3. The fact that no detectable defect in either SLN or ATP-2A1 (Zhang et al., 1995) had been found in patient F3P3 (recessive), who had been reported to be devoid of SERCA1 (Karpati et al., 1986) , led us to a reexamination of ATP2A1 in this patient and his brother (patient 2 in Karpati et al., 1986) . Haplotyping of the region surrounding ATP2A1 as described by Odermatt et al. (1996) showed that these brothers had the identical haplotype on both chromosomes, indicating homozygosity in this region (not shown). The fact that the parents in this family were first cousins is consistent with this degree of homozygosity.
Resequencing of ATP2A1 from patient F3P3 showed the presence of the T for C678 polymorphism noted earlier (Zhang et al., 1995) , but this time the deletion FIG. 6. Southern blot analysis of the SLN gene. A multiple speof a C in a series of three Cs (cDNA nucleotides 437 cies Southern blot (Clontech) was probed with the 350 bp HSAF12to 439) was detected (Fig. 7) . This deletion led to a HSAR8 PCR product, specific for the 5 region of the human SLN homozygous frame shift at Pro 147 , which would lead to gene, and washed under low-stringency conditions (60ЊC: 21 SSC, 0.05% SDS). Positions of DNA size markers are indicated on the left. a stop codon in both transcripts after the incorporation (1996) . b Benders et al. (1994) . c Unaffected father. d Karpati et al. (1986) . e Unaffected. f Zhang et al. (1995) .
of 33 additional amino acids. This mutation is very the cDNA is present in our pcDX library, as described here, and is present in other libraries from both skele-similar to the two cases of ATP2A1-linked Brody disease described earlier (Odermatt et al., 1996) in that tal and cardiac muscle (Washington School of Medicine-Merck EST project, GenBank). In this study, we mutations in both alleles led to premature termination codons and to truncation of SERCA1. In three of four cloned the SLN gene from our full-length rabbit skelecases of autosomal recessive inheritance of Brody distal muscle cDNA library in the pcDX vector by a novel ease described to date, SERCA1 protein has been lost application of inverse long PCR. In this method, the due to these truncations (Table 2) . Our results suggest vector sequence, containing an antibiotic resistance that mutations in ATP2A1, leading to a predicted funcmarker, was coamplified with the full-length cDNA, tional knock-out of SERCA1, account for the majority allowing us to self-ligate the PCR product and use the of autosomal recessive forms of Brody disease, but not circularized DNA directly for transformation of compefor dominant forms of the disease. tent bacterial cells. Since self-ligation was very efficient, as little as 1 ng of circularized PCR product was sufficient for successful cloning. By inverse long PCR,
DISCUSSION
products up to 8 kb in length have been obtained. Accordingly, this method has potential application for di-Cloning of Rabbit and Human SLN by Application rect cloning of even very long cDNAs inserted into vecof Inverse Long PCR Several earlier attempts in our tors of the usual length of about 4 kb. For example, we laboratory to clone SLN by hybridization screening of a skeletal muscle library were unsuccessful, even though have successfully cloned full-length ATP2A1 cDNAs of FIG. 7. Analysis of the deletion of one of the three Cs in nucleotide positions 437, 438, and 439, numbered according to the cDNA sequence of the ATP2A1 gene encoding SERCA1 (Zhang et al., 1995) , in family BD3. PCR amplified ATP2A1 genomic DNA was sequenced, and the deletion of one of the three Cs at Nucleotides 437, 438, or 439, leading to a frameshift beginning with the codon for Pro 147 , is indicated by an arrow. The effect of the mutation on amino acid sequences is shown beneath. The G-track and the nucleotide sequences of the homozygous mutant DNAs of the two affected brothers, F3P3 and F3P4, and two unrelated control DNAs, C1 and C2, are indicated.
3.5 kb from our pcDX library. The use of Pfu polymer-served hydrophobic transmembrane sequence, and perfect conservation of the C-terminal hydrophilic ase to avoid PCR artifacts is strongly recommended.
We also applied inverse long PCR to a human skele-sequence, which, by analogy with the well-characterized structure of phospholamban (Fujii et al., 1991) , tal muscle 5 stretch cDNA library in lgt11 to clone human SLN. The phage DNA was digested with an should lie in the lumen of the sarcoplasmic reticulum.
The functional consequences of the different charge dis-enzyme flanking the cDNA at both sides, and the circularized DNA was used as a template for inverse long tribution in the cytoplasmic domain of SLN in the three species are not clear. By contrast, SERCA1, with which PCR. The disadvantage of using phage library templates is the lack of a selectable marker on the ampli-SLN seems to interact, is highly conserved between rabbit and human (Zhang et al., 1995) . The low level fied product. Accordingly, it is necessary to recover much higher yields of the PCR product for cloning into of conservation of the SLN cDNA between different species is also reflected in the weak hybridization sig-a plasmid vector.
nal obtained on a Zoo blot using a human SLN probe.
Upstream Region of the Human SLN gene
One or two main bands were detected in all species tested, except yeast (Fig. 6 ). In the SLN gene, a cluster of three TATA box elements is located about 40 bp upstream of a CCAAT Relationship between SLN and PLN Genes box, which, in turn, is found 700 bp upstream of our proposed transcriptional start site. A similar unusual
The human SLN and PLN (Fujii et al., 1991) genes arrangement of CCAAT and TATA box elements was share common features, consistent with their origin in described for the skeletal muscle RYR1 gene (Phillips a common ancestor. Both genes contain two exons and et al., 1996) , with a CCAAT sequence 68 bp upstream one intron. In both cases, the intron is located about of the transcription initiation site and a cluster of five 90 bp downstream of the transcription initiation site, TATA box elements a further 1500 bp upstream. A and in both cases it interrupts the 5 untranslated sebinding site for the myocyte enhancer factor, MEF2, in quence, so that the entire coding sequence is located in combination with a MEF3-like element, follows just exon 2. The introns are relatively large, about 3.9 kb upstream of the TATA box cluster in the SLN gene. long in SLN and about 6 kb long in PLN. The 3 ends The muscle-specific induction of the aldolase A gene of both genes contain multiple polyadenylation signals, has been shown to be controlled through cooperation and more than one polyadenylation site is used in both between the muscle-specific factor MEF2 and the more genes (Fujii et al., 1988) . Alignment of human SLN ubiquitous factor MEF3 (Hidaka et al., 1993) . An addiand PLN cDNA reveals 60% nucleotide identity in the tonal MEF3-like site is located 200 bp downstream of region encoding the predicted transmembrane helices, the CCAAT box in the SLN gene. The 5 region of the even though only 30% identity is observed for the N-SLN gene contains several E boxes (CANNTG). E terminal and C-terminal domains (not shown). boxes, which are recognized by the MyoD family of ba-On the basis of the conservation of amino acids in sic -helix-loop-helix transcriptional activators, occur parts of the N-termini and much of the transmembrane by chance every 250 bp in DNA sequences. However, helices of SLN and PLN, we propose that SLN and MyoD has been shown to bind cooperatively to paired PLN are homologous proteins. It is possible that they sites with a 19-bp space in the muscle creatine kinase have achieved this degree of sequence identity by conenhancer (Weintraub et al., 1990) and to paired sites vergent evolution, but, in light of the similarity in gene with a 12-bp space in the acetylcholine receptor a-substructure, it seems much more likely that sequence unit enhancer (Piette et al., 1990) . In the SLN gene, similarity is based on divergent evolution from a comtwo E box pairs with 11 and 10 bp space between both mon gene. E boxes follow about 200 and 500 bp downstream of The differences in the N-and C-terminal sequences the CCAAT box. These DNA binding elements might of SLN and PLN must reflect their different interacbe responsible for the muscle-specific expression of the tions with different cytoplasmic proteins (PLN is phos-SLN gene revealed by Northern analysis. In contrast phorylated by protein kinase A, but SLN is not), but to the ATP2A1 gene (Korczak et al., 1988) and the their conserved transmembrane sequences suggest re-RYR1 gene (Phillips et al., 1996) , Sp1 sites and the tention of the ability to interact with conserved transproposed muscle-specific promoter element GGCmembrane sequences in other proteins. The three TGGGG are absent from the SLN promoter region.
SERCA molecules (Burk et al., 1989) are the most likely candidates for such interactions. PLN is coexpressed
Conservation of SLN in Different Species
with SERCA2a and interacts functionally with it. PLN also retains the capacity to inhibit SERCA1 (Toyofuku Alignment of amino acid sequences of SLN from human, rabbit, and mouse (this study ; Washington School et al., 1993) , but does not do so because the two proteins are not coexpressed in the same tissue. SLN is most of Medicine-Merck EST project, GenBank; Wawrzynow et al., 1992) revealed poor conservation of the hy-highly expressed in fast-twitch muscle, where SERCA1 is highly expressed and the two proteins copurify (Mac-drophilic N-terminal sequence, a relatively well-con- Lennan et al., 1972) . In our most recent in vitro coex-gain inhibitory function leading to the morbidity associated with a highly inhibited form of SERCA1, we ini-pression experiments, we have found that SLN inhibits SERCA1 by decreasing its apparent affinity for Ca 2/ tiated a search for SLN mutants in the four Brody families with non-ATP2A1-linked Brody disease and with (A. Odermatt, S. Becker, V. K. Khanna, K. Kurzydlowski, and D. H. MacLennan, unpublished) . Since PLN a fifth family available to us. Unfortunately, we did not find any alterations that would support SLN as a inhibits the activity of SERCA2a by decreasing its apparent affinity for Ca 2/ , SLN may act as the counter-candidate gene for Brody disease in these five families.
In additional studies of BD, we showed that two part of PLN in fast-twitch skeletal muscle.
Transmembrane helices M4, M5, and M6, which are brothers in family BD3, in which ATP2A1 mutations had not been found in an earlier study (Zhang et al. , key to Ca 2/ binding and translocation in SERCA1 (Rice and MacLennan, 1996) , are highly conserved in all 1995), shared a common haplotype on chromosome 16p12.1-p12.2, suggesting the need for reevaluation of three SERCA molecules. Thus the three transmembrane sequences in SERCA molecules and the single the role of the ATP2A1 gene in the disease. This led us to resequence ATP2A1 in this family and to the discov-transmembrane sequence in SLN/PLN molecules may have coevolved, conferring a degree of evolutionary sta-ery of a fourth BD mutation that would truncate SERCA1. Currently four mutations in three BD fami-bility on each other. The cytoplasmic domain of PLN also interacts with a cytoplasmic domain of SERCA2a lies are known, all resulting in recessive inheritance of BD. The only recessive BD family that has not been (Toyofuku et al., 1994) . This site is conserved in SER-CA1, but is missing from SERCA3.
shown to have an ATP2A1 mutation is BD4 (Table 2) . We are currently haplotyping two brothers in this fam-The SLN gene is expressed most abundantly in fasttwitch skeletal muscle (Fig. 5C ), the tissue in which ily to determine whether resequencing of ATP2A1 might be warranted. In three other BD families where SERCA1 is expressed almost exclusively. This is also the tissue from which SLN was first isolated, in associ-inheritance is dominant (Table 2) , the causal gene has yet to be discovered. ation with highly purified SERCA1 (MacLennan et al., 1972) . Like SERCA1 expression (Wu and Lytton, 1993) , SLN localizes to human chromosome 11q22-q23, a region frequently deleted in several hematological ma-SLN expression is 10 times lower in slow-twitch skeletal muscle (soleus) than in fast-twitch skeletal muscle lignancies. In acute leukemias, the MLL (ALL1, HRX, and HTRX) gene, which maps to 11q23, is involved in (WST, EDL). In cardiac tissue, the concentration of the SLN transcript is about 50-fold less abundant than it is reciprocal translocations with a large number of gene partners (Bernard and Berger, 1995) . Leukemias mani-in skeletal muscle (Fig. 5A) . SLN expression is another order of magnitude lower in pancreas and prostate ( Fig. festing 11q23 rearrangements have been shown to be associated with very poor prognosis (Rasio et al., 1996) . 5B), where SERCA2b predominates. PLN is expressed most abundantly in cardiac and slow-twitch skeletal This region also seems to be sensitive to DNA topoisomerase II inhibitors, as the majority of therapy-related muscle, where SERCA2a is the predominant SERCA molecule, and at much lower levels in fast-twitch skele-leukemias resulting from treatment with these inhibitors demonstrate MLL rearrangements (Canaani et al., tal muscle and smooth muscle (Fujii et al., 1988) . Thus SLN and PLN are expressed in muscle-specific and 1995). Cultured cells harboring such deletions might provide an interesting experimental system for the in-complementary patterns, and the patterns of their expression are directly correlated with the expression of vestigation of the function of SLN in cell physiology. different SERCA molecules in each muscle tissue. On the basis of data presented in this paper, we propose
